Abstract
A 24-year-old woman with Rasmussen encephalitis diagnosed at age 6 years underwent investigation of involuntary movements. She developed continuous left-sided hemichoreoathetosis at age 11 after addition of valproic acid (VPA) to carbamazepine and phenobarbital therapy. Admission workup was unremarkable, except for toxic VPA levels (129 mg/L). Cessation of movements was observed the day after VPA was discontinued (Video 1).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
